Safety evaluation of the food enzyme maltogenic amylase from genetically modified Escherichia coli (strain BLASC)

被引:0
作者
Silano, Vittorio
Baviera, Jose Manuel Barat
Bolognesi, Claudia
Cocconcelli, Pier Sandro
Crebelli, Riccardo
Gott, David Michael
Grob, Konrad
Lampi, Evgenia
Mortensen, Alicja
Riviere, Gilles
Steffensen, Inger-Lise
Tlustos, Christina
Van Loveren, Henk
Vernis, Laurence
Zorn, Holger
Glandorf, Boet
Herman, Lieve
Jany, Klaus-Dieter
Marcon, Francesca
Penninks, Andre
Arcella, Davide
Gomes, Ana
Kovalkovicova, Natalia
Liu, Yi
Maia, Joaquim
Pena, Claudia Roncancio
Nuin, Irene
Chesson, Andrew
机构
关键词
food enzyme; maltogenic amylase; glucan; 1,4-alpha-maltohydrolase; EC; 3.2.1.133; Escherichia coli; genetically modified microorganism; ASPERGILLUS-DERIVED ENZYMES; ALPHA-AMYLASE; ALLERGY; RESPONSES; BREAD;
D O I
10.2903/j.efsa.2019.5769
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The food enzyme, a maltogenic amylase (glucan 1,4-alpha-maltohydrolase; EC 3.2.1.133), is produced with a genetically modified Escherichia coli strain BLASC by Advanced Enzyme Technologies Ltd. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This maltogenic amylase is intended to be used in baking and brewing processes and starch processing for the production of glucose syrups. Residual amounts of total organic solids (TOS) are removed by the purification steps applied during the production of glucose syrups; consequently, dietary exposure was not calculated for this food process. For baking and brewing processes, based on the maximum use levels recommended for food processes and individual data from the EFSA Comprehensive European Food Database, dietary exposure to the food enzyme-TOS was estimated to be up to 0.107 mg TOS/kg body weight (bw) per day. Genotoxicity tests did not raise a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level at the highest dose tested of 838 mg TOS/kg bw per day that, compared with the estimated dietary exposure, resulted in a sufficiently high margin of exposure (at least 7,800). Similarity of the amino acid sequence to those of known allergens was searched and one match was found with respiratory allergen produced by Aspergillus oryzae. The Panel considered that, under the intended conditions of use, the risk for allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood of such reaction to occur is considered to be low. Based on the data provided, the Panel concluded that this food enzyme does not raise safety concerns under the intended conditions of use. (C) 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
引用
收藏
页数:16
相关论文
共 23 条
  • [1] Guidance of the Scientific Panel of Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) on the Submission of a Dossier on Food Enzymes for Safety Evaluation by the Scientific Panel of Food Contact Material, Enzymes, Flavourings and Processing Aids
    Anadon, Arturo
    Bell, David
    Binderup, Mona-Lise
    Bursch, Wilfried
    Castle, Laurence
    Crebelli, Riccardo
    Engel, Karl-Heinz
    Franz, Roland
    Gontard, Nathalie
    Haertle, Thomas
    Husoy, Trine
    Jany, Klaus-Dieter
    Leclercq, Catherine
    Lhuguenot, Jean-Claude
    Mennes, Wim C.
    Milana, Maria Rosaria
    Pfaff, Karla
    Svensson, Kettil
    Toldra, Fidel
    Waring, Rosemary
    Woelfle, Detlef
    [J]. EFSA JOURNAL, 2009, 7 (08)
  • [2] Guidance on the risk assessment of genetically modified microorganisms and their products intended for food and feed use EFSA Panel on Genetically Modified Organisms (GMO)
    Andersson, Hans Christer
    Arpaia, Salvatore
    Bartsch, Detlef
    Casacuberta, Josep
    Davies, Howard
    du Jardin, Patrick
    Flachowsky, Gerhard
    Herman, Lieve
    Jones, Huw
    Kaerenlampi, Sirpa
    Kiss, Jozsef
    Kleter, Gijs
    Kuiper, Harry
    Messean, Antoine
    Nielsen, Kaare Magne
    Perry, Joe
    Poeting, Annette
    Sweet, Jeremy
    Tebbe, Christoph
    von Wright, Atte Johannes
    Wal, Jean-Michel
    [J]. EFSA JOURNAL, 2011, 9 (06)
  • [3] [Anonymous], 1997, BACT REV MUT TEST
  • [4] Why can patients with baker's asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant?
    Armentia, A.
    Diaz-Perales, A.
    Castrodeza, J.
    Duenas-Laita, A.
    Palacin, A.
    Fernandez, S.
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2009, 37 (04) : 203 - 204
  • [5] Guidance of the Scientific Committee on a request from EFSA related to Uncertainties in Dietary Exposure Assessment Request No EFSA-Q-2004-019 Adopted on 14 December 2006
    Barlow, Sue
    Chesson, Andrew
    Collins, John
    Dybing, Erik
    Flynn, Albert
    Fruijtier-Polloth, Claudia
    Hardy, Tony
    Knaap, Ada
    Kuiper, Harry
    Le Neindre, Pierre
    Schans, Jan
    Schlatter, Josef
    Silano, Vittorio
    Skerving, Steffan
    Vannier, Philippe
    [J]. EFSA JOURNAL, 2007, 5 (01)
  • [6] Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements
    Barlow, Susan
    Chesson, Andrew
    Collins, John D.
    Flynn, Albert
    Galli, Corrado L.
    Hardy, Anthony
    Jany, Klaus-Dieter
    Jeger, Michael-John
    Knaap, Ada
    Kuiper, Harry
    Larsen, John-Christian
    Lovell, David
    Schlatter, Josef
    Silano, Vittorio
    Smulders, Frans
    Vannier, Philippe
    [J]. EFSA JOURNAL, 2009, 7 (09)
  • [7] ALLERGIC REACTION AFTER EATING ALPHA-AMYLASE (ASP-O-2)-CONTAINING BREAD
    BAUR, X
    CZUPPON, AB
    [J]. ALLERGY, 1995, 50 (01) : 85 - 87
  • [8] BRISMAN J, 1991, BRIT J IND MED, V48, P604
  • [9] Baker's asthma
    Brisman, J
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 59 (07) : 498 - 502
  • [10] Clinical responses to ingested fungal alpha-amylase and hemicellulase in persons sensitized to Aspergillus fumigatus?
    Cullinan, P
    Cook, A
    Jones, M
    Cannon, J
    Fitzgerald, B
    Taylor, AJN
    [J]. ALLERGY, 1997, 52 (03) : 346 - 349